MT-TL2 Gene Encephalomyopathy Mitochondrial MT-TL2 Related Genetic Test
Welcome to DNA Labs UAE, where we offer the MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related genetic test. This diagnostic test is used to detect mutations in the MT-TL2 gene that are associated with mitochondrial encephalomyopathy.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related NGS genetic DNA test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related.
Test Details
The MT-TL2 gene encephalomyopathy mitochondrial MT-TL2 related NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to sequence the entire MT-TL2 gene. This allows for the identification of any mutations or variations that may be present. Mitochondrial encephalomyopathy is a rare genetic disorder that affects the function of mitochondria, the energy-producing organelles within cells. Symptoms of this disorder can include muscle weakness, seizures, developmental delays, and cognitive impairment. Mutations in the MT-TL2 gene have been linked to mitochondrial encephalomyopathy.
Genetic testing plays a crucial role in diagnosing mitochondrial encephalomyopathy and guiding treatment decisions. NGS genetic testing is a powerful tool for detecting mutations in the MT-TL2 gene and other genes associated with mitochondrial disorders. This technology allows for the rapid and accurate sequencing of large stretches of DNA, making it possible to identify even rare mutations that may be missed by other diagnostic tests. NGS testing is often used in conjunction with other diagnostic tools, such as clinical evaluations and biochemical tests, to provide a comprehensive diagnosis of mitochondrial encephalomyopathy and other mitochondrial disorders.
Test Name | MT-TL2 Gene Encephalomyopathy mitochondrial MT-TL2 related Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MT-TL2 Gene Encephalomyopathy, mitochondrial, MT-TL2 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TL2 Gene Encephalomyopathy, mitochondrial, MT-TL2 related |
Test Details |
MT-TL2 gene encephalomyopathy, mitochondrial, MT-TL2 related NGS genetic test is a diagnostic test used to detect mutations in the MT-TL2 gene that are associated with mitochondrial encephalomyopathy. This test uses next-generation sequencing (NGS) technology to sequence the entire MT-TL2 gene and identify any mutations or variations that may be present. Mitochondrial encephalomyopathy is a rare genetic disorder that affects the function of mitochondria, the energy-producing organelles within cells. Symptoms of this disorder can include muscle weakness, seizures, developmental delays, and cognitive impairment. Mutations in the MT-TL2 gene have been linked to mitochondrial encephalomyopathy, and genetic testing can help diagnose this disorder and guide treatment decisions. NGS genetic testing is a powerful tool for detecting mutations in the MT-TL2 gene and other genes associated with mitochondrial disorders. This technology allows for the rapid and accurate sequencing of large stretches of DNA, making it possible to identify even rare mutations that may be missed by other diagnostic tests. NGS testing is often used in conjunction with other diagnostic tools, such as clinical evaluations and biochemical tests, to provide a comprehensive diagnosis of mitochondrial encephalomyopathy and other mitochondrial disorders. |